|
| | Issue Date | Title | Author(s) |
| 21 | 2017 | An overview on the prospective CDKs inhibitors as anti-cancer drugs | Oudah, Khulood H; Serya, R; Abouzid, K; Serya, Rabah ; Nermin Samir |
| 22 | 30-Jan-2017 | Click and Release: SO2 Prodrugs with Tunable Release Rates | Serya, Rabah ; Khaled A.M.abouzid; Deena S.Lasheen; Xingyue Ji; Binghe Wang; Khaled A M Abouzid |
| 23 | 6-Jul-2017 | Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2) | Mehanna, Wesam E; Lu, Tiangong; Debnath, Bikash; Lasheen, Deena S. ; Serya, Rabah A T ; Abouzid, Khaled ; Neamati, Nouri |
| 24 | 1-Dec-2017 | Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity | Aly, Rasha M.; Serya, Rabah ; El-Motwally, Amira M.; Abbas, Safinaz; Abou El Ella, Dalal ; Esmat, Ahmed |
| 25 | 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| 26 | 25-May-2018 | Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens | ElAwamy, Moustafa; Mohammad, Haroon; Hussien, Abdelrahman; Abutaleb, Nader S; Hagras, Mohamed; Serya, Rabah ; Taher, Azza T; Seleem, Mohamed N; Mayhoub, Abdelrahman S; Khaled A M Abouzid |
| 27 | 15-Jul-2018 | Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors | Milik, Sandra N; Serya, Rabah ; Minucci, Saverio; Lasheen, Deena S. ; Khaled A M Abouzid ; Abdel-Aziz, Amal Kamal |
| 28 | Sep-2018 | Pyrrolopyrimidine, A Multifaceted Scaffold in Cancer Targeted Therapy | Adel, Mai; Serya, Rabah A T ; Lasheen, Deena S. ; Abouzid, Khaled |
| 29 | Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
| 30 | 2019 | Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation | Shalaby, Menna-Allah; Dokla, Eman ; Serya, Rabah ; Abouzid, Khaled |
| 31 | 2019 | Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors | Oudah, Khulood H; Najm, Mazin A A; Samir, Nermin ; Serya, Rabah ; Khaled A M Abouzid |
| 32 | 2019 | Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity | Elsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 33 | 2019 | Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy | Ibrahim, Hoda Sobhy; Lasheen, Deena S; Serya, Rabah ; Abu-ELElla, Dalal Abd-ELRahman |
| 34 | Dec-2019 | Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activities | Jaballah, Maiy Y; Serya, Rabah ; Saad, Nasser; Khojah, Sohair M; Ahmed, Marawan; Barakat, Khaled; Khaled A M Abouzid |
| 35 | 2020 | Synthesis, Biological Evaluation and In Silico Investigation of Novel Functionalized Imidazole-Based KDM6 Inhibitors | Serya, Rabah ; El-Araby, Amr; Qassem, Omar; El-Sawy, Ezzat; El-Razaz, Eman; Abouzid, Khaled |
| 36 | 1-Aug-2020 | Penicillin binding protein 2a: An overview and a medicinal chemistry perspective | Shalaby, Menna-Allah W; Dokla, Eman ; Serya, Rabah ; Khaled A M Abouzid |
| 37 | Aug-2021 | Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations | Elrazaz, Eman ; Serya, Rabah A T ; Ismail, Nasser S M; Albohy, Amgad; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 38 | Dec-2021 | Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer | Abdel-Atty, Mona M; Farag, Nahla A; Serya, Rabah A T ; Abouzid, Khaled ; Mowafy, Samar |
| 39 | Feb-2022 | Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity | Farahat, Aya A; Samir, Eman M; Zaki, Mayssoune Y; Abdel-Aziz, Hatem A; Serya, Rabah |
| 40 | Dec-2022 | Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells | Abdelhafiz, Abeer H A; Lasheen, Deena S. ; Wang, Nessa; Sobeh, Mansour; Wink, Michael; Abouzid, Khaled ; Serya, Rabah |
Loading...